Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-24	2.06e-11	37	109	8	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-24	2.59e-11	38	109	8	GO:0070001
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	2.69e-07	11	109	4	GO:0004523
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	8.06e-07	14	109	4	GO:0003964
GeneOntologyMolecularFunction	endopeptidase activity	ERVK-6 CAPN14 CLCA4 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 PRSS45P MME ERVK-24	4.06e-06	430	109	12	GO:0004175
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-10 ERVK-8	4.68e-06	21	109	4	GO:0035613
GeneOntologyMolecularFunction	peptidase activity	ERVK-6 CAPN14 CLCA4 ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP32 ERVK-8 ERVK-19 PRSS45P MME ERVK-24 COPS5	1.29e-05	654	109	14	GO:0008233
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8	4.83e-05	37	109	4	GO:0016891
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	5.37e-05	38	109	4	GO:0034061
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8	1.15e-04	46	109	4	GO:0016893
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	SI MGAM2	2.92e-04	5	109	2	GO:0004558
GeneOntologyMolecularFunction	D-mannose binding	MRC1 MANBA CLEC4M	4.21e-04	27	109	3	GO:0005537
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	PMS1 ERVK-6 CHD1 ERVK-7 ERVK-10 TDP2 ERVK-8	5.90e-04	262	109	7	GO:0140097
GeneOntologyMolecularFunction	alpha-glucosidase activity	SI MGAM2	6.09e-04	7	109	2	GO:0090599
GeneOntologyMolecularFunction	endonuclease activity	ERVK-6 ERVK-7 ERVK-10 TDP2 ERVK-8	9.02e-04	136	109	5	GO:0004519
GeneOntologyMolecularFunction	protein phosphatase 1 binding	SHOC2 LILRB1 FER	9.12e-04	35	109	3	GO:0008157
GeneOntologyMolecularFunction	RNA endonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	9.22e-04	79	109	4	GO:0004521
GeneOntologyMolecularFunction	protein phosphatase binding	FCRL2 SHOC2 LILRB1 PTPRT GAB2 FER	1.04e-03	210	109	6	GO:0019903
GeneOntologyMolecularFunction	zinc ion binding	CA9 ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TRIM14 ZMIZ2 ERVK-8 ERVK-19 MME ERVK-24 ALPI	1.14e-03	891	109	13	GO:0008270
GeneOntologyMolecularFunction	nuclease activity	ERVK-6 ASTE1 ERVK-7 ERVK-10 TDP2 ERVK-8	1.69e-03	231	109	6	GO:0004518
GeneOntologyMolecularFunction	peptide binding	CACNA1A HFE CLEC4M LILRB1 MICB MME KPNA2	1.81e-03	318	109	7	GO:0042277
GeneOntologyMolecularFunction	monosaccharide binding	MRC1 MANBA CLEC4M PKLR	1.83e-03	95	109	4	GO:0048029
GeneOntologyMolecularFunction	transition metal ion binding	CA9 ERVK-6 APLP2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TRIM14 TDP2 ZMIZ2 ERVK-8 ERVK-19 MME ERVK-24 ALPI	2.01e-03	1189	109	15	GO:0046914
GeneOntologyMolecularFunction	peptide antigen binding	HFE CLEC4M MICB	2.43e-03	49	109	3	GO:0042605
GeneOntologyMolecularFunction	glutamate binding	GRIK1 GCLC	2.57e-03	14	109	2	GO:0016595
GeneOntologyBiologicalProcess	viral process	ERVK-6 MRC1 RRP1B CHD1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 CLEC4M TRIM14 RESF1 ERVK-8 ERVK-19 ERVK-24 KPNA2	1.97e-08	464	108	15	GO:0016032
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-10 ERVK-8	4.90e-07	13	108	4	GO:0015074
GeneOntologyBiologicalProcess	cell-cell fusion	ERVK-6 ERVK-21 ERVK-9 DOCK5 ERVK-8 ERVK-19	5.60e-06	85	108	6	GO:0140253
GeneOntologyBiologicalProcess	syncytium formation by plasma membrane fusion	ERVK-6 ERVK-21 ERVK-9 DOCK5 ERVK-8 ERVK-19	5.60e-06	85	108	6	GO:0000768
GeneOntologyBiologicalProcess	syncytium formation	ERVK-6 ERVK-21 ERVK-9 DOCK5 ERVK-8 ERVK-19	7.32e-06	89	108	6	GO:0006949
GeneOntologyBiologicalProcess	adult behavior	CACNA1A KLHL1 GRIK1 BTBD9 CHRNB4 DMRT3 SDK1	9.71e-05	203	108	7	GO:0030534
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 ERVK-7 ERVK-10 ERVK-8	1.16e-04	48	108	4	GO:0000731
HumanPheno	Recurrent Haemophilus influenzae infections	HFE CLCA4 GCLC SCNN1A	9.87e-06	25	29	4	HP:0005376
HumanPheno	Elevated sweat chloride	HFE CLCA4 GCLC SCNN1A	1.36e-05	27	29	4	HP:0012236
HumanPheno	Abnormal sweat homeostasis	HFE CLCA4 GCLC SCNN1A	1.82e-05	29	29	4	HP:0040127
HumanPheno	Malabsorption	PMS1 HFE CLCA4 SI KMT2D GCLC PKHD1 ABCB11	3.37e-05	235	29	8	HP:0002024
HumanPheno	Fat malabsorption	HFE CLCA4 GCLC PKHD1 ABCB11	3.90e-05	70	29	5	HP:0002630
HumanPheno	Recurrent gram-negative bacterial infections	HFE CLCA4 GCLC SCNN1A	4.92e-05	37	29	4	HP:0005420
HumanPheno	Abnormal blood chloride concentration	HFE CLCA4 GCLC SCNN1A	6.07e-05	39	29	4	HP:0011422
HumanPheno	Abnormal blood ion concentration	HFE CLCA4 SERPINA6 TDP2 STAT2 CLCN2 GCLC PKLR SCNN1A PKHD1	1.02e-04	445	29	10	HP:0003111
HumanPheno	Nontuberculous mycobacterial pulmonary infection	HFE CLCA4 GCLC	2.06e-04	21	29	3	HP:0032261
HumanPheno	Meconium ileus	HFE CLCA4 GCLC	2.38e-04	22	29	3	HP:0004401
HumanPheno	Abnormal vas deferens morphology	HFE CLCA4 GCLC	2.38e-04	22	29	3	HP:0012872
HumanPheno	Absent vas deferens	HFE CLCA4 GCLC	2.38e-04	22	29	3	HP:0012873
HumanPheno	Mechanical ileus	HFE CLCA4 GCLC	2.38e-04	22	29	3	HP:0010676
HumanPheno	Recurrent Burkholderia cepacia infections	HFE CLCA4 GCLC	2.72e-04	23	29	3	HP:0002842
HumanPheno	Cirrhosis	HFE CLCA4 GCLC PKHD1 ABCB11 MED12	2.79e-04	166	29	6	HP:0001394
HumanPheno	Glucocortocoid-insensitive primary hyperaldosteronism	CLCN2 SCNN1A	3.10e-04	5	29	2	HP:0011740
HumanPheno	Decreased body mass index	HFE CLCA4 GCLC	3.51e-04	25	29	3	HP:0045082
HumanPheno	Recurrent Aspergillus infections	HFE CLCA4 GCLC	3.51e-04	25	29	3	HP:0002724
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-10 ERVK-24	1.02e-10	4	112	4	10469592
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19	2.46e-10	12	112	5	14557543
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-21 ERVK-19	5.08e-10	5	112	4	12629516
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-24	7.94e-10	94	112	8	21542922
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-6 ERVK-10 ERVK-19	1.30e-07	4	112	3	7983737
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-21 ERVK-9 ERVK-10 ERVK-24	3.01e-07	18	112	4	18664271
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-6 ERVK-9 ERVK-19	6.46e-07	6	112	3	15063128
Pubmed	Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins.	ERVK-6 ERVK-21 ERVK-19	3.84e-06	10	112	3	12970426
Pubmed	Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.	SHOC2 PTPN11	1.03e-05	2	112	2	21548061
Pubmed	Tensins are versatile regulators of Rho GTPase signalling and cell adhesion.	DOCK5 TNS3	1.03e-05	2	112	2	27748980
Pubmed	The Kelch-like protein 1 modulates P/Q-type calcium current density.	CACNA1A KLHL1	1.03e-05	2	112	2	17289272
Pubmed	Determining folding and binding properties of the C-terminal SH2 domain of SHP2.	GAB2 PTPN11	1.03e-05	2	112	2	34605082
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	1.03e-05	2	112	2	9060628
Pubmed	Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.	ERVK-6 ERVK-19	1.03e-05	2	112	2	9460924
Pubmed	Natural killer cell profiles in recurrent pregnancy loss: Increased expression and positive associations with TACTILE and LILRB1.	LILRB1 CD96	1.03e-05	2	112	2	36004818
Pubmed	Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.	GAB2 PTPN11	1.03e-05	2	112	2	15170389
Pubmed	A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.	GAB2 PTPN11	3.08e-05	3	112	2	20651068
Pubmed	Elevated expressions of SHP2 and GAB2 correlated with VEGF in eutopic and ectopic endometrium of women with ovarian endometriosis.	GAB2 PTPN11	3.08e-05	3	112	2	32619126
Pubmed	Molecular analysis of homeostatic iron regulator, transmembrane protease serine-6, and BTB domain-containing protein-9 variants and iron parameters in blood donors.	HFE BTBD9	3.08e-05	3	112	2	33367529
Pubmed	Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.	ERVK-6 ERVK-19	3.08e-05	3	112	2	10516026
Pubmed	SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.	RAE1 KPNA2	3.08e-05	3	112	2	33097660
Pubmed	Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.	ERVK-6 ERVK-9	3.08e-05	3	112	2	9971820
Pubmed	Rotavirus inhibits IFN-induced STAT nuclear translocation by a mechanism that acts after STAT binding to importin-α.	STAT2 KPNA2	3.08e-05	3	112	2	24814927
Pubmed	Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.	PKHD1 ABCB11	3.08e-05	3	112	2	25771912
Pubmed	BCR mediated signal transduction in immature and mature B cells.	GAB2 MAPK4	3.08e-05	3	112	2	12008033
Pubmed	MLL2 regulates glucocorticoid receptor-mediated transcription of ENACα in human retinal pigment epithelial cells.	KMT2D SCNN1A	3.08e-05	3	112	2	32139118
Pubmed	Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits.	HFE MRC1 TOMM40	4.14e-05	21	112	3	21943158
Pubmed	Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase.	GAB2 PTPN11	6.14e-05	4	112	2	19909739
Pubmed	Molecular interactions of SHP1 and SHP2 in IL-3-signalling.	GAB2 PTPN11	6.14e-05	4	112	2	11812650
Pubmed	Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.	GAB2 PTPN11	6.14e-05	4	112	2	23401857
Pubmed	Phosphatidylinositol 3-kinase regulates glycosylphosphatidylinositol hydrolysis through PLC-gamma(2) activation in erythropoietin-stimulated cells.	GAB2 PTPN11	6.14e-05	4	112	2	12135708
Pubmed	Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.	GAB2 PTPN11	6.14e-05	4	112	2	27840422
Pubmed	Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.	GAB2 PTPN11	6.14e-05	4	112	2	22806893
Pubmed	Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation.	GAB2 PTPN11	6.14e-05	4	112	2	15356145
Pubmed	β1Pix exchange factor stabilizes the ubiquitin ligase Nedd4-2 and plays a critical role in ENaC regulation by AMPK in kidney epithelial cells.	ARHGEF7 SCNN1A	6.14e-05	4	112	2	29858246
Pubmed	A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners.	GAB2 PTPN11	6.14e-05	4	112	2	11334882
Pubmed	Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes.	GAB2 PTPN11	6.14e-05	4	112	2	27025927
Pubmed	Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs.	CENPF KPNA2	6.14e-05	4	112	2	9497340
Pubmed	Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.	FADS1 ABCB11 TOMM40	8.01e-05	26	112	3	19060910
Pubmed	Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells.	CA9 XPOT KPNA2	8.01e-05	26	112	3	23181366
Pubmed	Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein.	GAB2 PTPN11	1.02e-04	5	112	2	16253990
Pubmed	Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane.	STAT2 KPNA2	1.02e-04	5	112	2	17596301
Pubmed	Differential effects of extracellular ATP on chloride transport in cortical collecting duct cells.	CLCA4 SCNN1A	1.02e-04	5	112	2	22647633
Pubmed	Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.	ERVK-6 ERVK-7	1.02e-04	5	112	2	11401426
Pubmed	SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors.	MRC1 CLEC4M	1.02e-04	5	112	2	32766577
Pubmed	Paxillin-dependent paxillin kinase linker and p21-activated kinase localization to focal adhesions involves a multistep activation pathway.	ARHGEF7 PKLR	1.02e-04	5	112	2	12006652
Pubmed	Mediator is a transducer of amyloid-precursor-protein-dependent nuclear signalling.	APLP2 MED12	1.02e-04	5	112	2	21293490
Pubmed	The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway.	GAB2 PTPN11	1.02e-04	5	112	2	16873377
Pubmed	Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.	CHD1 GAB2 PTPN11	1.24e-04	30	112	3	12522270
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PMS1 RRP1B RALGAPB APLP2 PPFIA3 SHOC2 PTPRT PTPN11 KMT2D TNS3 XPOT KPNA2	1.48e-04	1049	112	12	27880917
Pubmed	Vaginal epithelial cell-derived S100 alarmins induced by Candida albicans via pattern recognition receptor interactions are sufficient but not necessary for the acute neutrophil response during experimental vaginal candidiasis.	MRC1 CLEC4M	1.53e-04	6	112	2	24478092
Pubmed	Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors.	GAB2 PTPN11	1.53e-04	6	112	2	10068651
Pubmed	Nerve growth factor activates persistent Rap1 signaling in endosomes.	GAB2 PTPN11	1.53e-04	6	112	2	11466412
Pubmed	Tensin 3 is a new partner of Dock5 that controls osteoclast podosome organization and activity.	DOCK5 TNS3	1.53e-04	6	112	2	27505886
Pubmed	Fer and Fps/Fes participate in a Lyn-dependent pathway from FcepsilonRI to platelet-endothelial cell adhesion molecule 1 to limit mast cell activation.	PTPN11 FER	1.53e-04	6	112	2	16731527
Pubmed	PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2.	GAB2 PTPN11	1.53e-04	6	112	2	11782427
Pubmed	The signaling adapter, FRS2, facilitates neuronal branching in primary cortical neurons via both Grb2- and Shp2-dependent mechanisms.	GAB2 PTPN11	1.53e-04	6	112	2	25159185
Pubmed	A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin development.	KLHL1 BTBD9 ARHGEF7 COPS5	1.85e-04	87	112	4	37495603
Pubmed	Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase.	GAB2 PTPN11	2.14e-04	7	112	2	11287610
Pubmed	Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.	GAB2 PTPN11	2.14e-04	7	112	2	10995764
Pubmed	Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling.	GAB2 PTPN11	2.14e-04	7	112	2	16371368
Pubmed	Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.	MRC1 CLEC4M	2.14e-04	7	112	2	17617634
Pubmed	Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1.	GAB2 PTPN11	2.14e-04	7	112	2	10391903
Pubmed	A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes.	GAB2 PTPN11	2.14e-04	7	112	2	9660791
Pubmed	Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors.	GAB2 PTPN11	2.14e-04	7	112	2	14982882
Pubmed	Hereditary Ataxia Overview	CACNA1A SYNE1 TDP2 MME	2.29e-04	92	112	4	20301317
Pubmed	Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development.	LILRB1 PTPN11	2.84e-04	8	112	2	22660330
Pubmed	Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP.	APLP2 MME	2.84e-04	8	112	2	15944124
Pubmed	Localization of the osteocalcin gene cluster on mouse chromosome 3.	PKLR MME	2.84e-04	8	112	2	7915557
Pubmed	Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses.	GAB2 PTPN11	3.65e-04	9	112	2	10871282
Pubmed	Role of the docking protein Gab2 in beta(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration.	GAB2 PTPN11	3.65e-04	9	112	2	11895767
Pubmed	Identification of two novel RanGTP-binding proteins belonging to the importin beta superfamily.	XPOT KPNA2	3.65e-04	9	112	2	11024021
Pubmed	Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.	JADE2 GAB2 ARHGEF7	4.46e-04	46	112	3	21102462
Pubmed	Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection.	MRC1 CLEC4M	4.55e-04	10	112	2	20488784
Pubmed	miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT.	TNRC6C CNOT3	4.55e-04	10	112	2	21984185
Pubmed	Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity.	LILRB1 PTPN11	5.55e-04	11	112	2	21364532
Pubmed	Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites.	GAB2 PTPN11	5.55e-04	11	112	2	31585087
Pubmed	Genetic background of lead and mercury metabolism in a group of medical students in Austria.	HFE GCLC	5.55e-04	11	112	2	19515364
Pubmed	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	GRIK1 PKHD1	5.55e-04	11	112	2	17903305
Pubmed	Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model.	LILRB1 PTPN11	5.55e-04	11	112	2	24052308
Pubmed	miRNA repression involves GW182-mediated recruitment of CCR4-NOT through conserved W-containing motifs.	TNRC6C CNOT3	5.55e-04	11	112	2	21984184
Pubmed	A global genomic transcriptional code associated with CNS-expressed genes.	KLHL1 PCMTD1 C2CD5 PKHD1 RAB27B KPNA2	5.92e-04	318	112	6	16919269
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	CENPF JADE2 FOSL2 KMT2D	6.09e-04	119	112	4	23508102
Pubmed	AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair.	PTPRT CHRNB4 DOCK5 PKHD1	6.48e-04	121	112	4	31900314
Pubmed	Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.	GAB2 PTPN11	6.64e-04	12	112	2	19172738
Pubmed	Novel CUL3 Variant Causing Familial Hyperkalemic Hypertension Impairs Regulation and Function of Ubiquitin Ligase Activity.	KLHL1 BTBD9 COPS5	8.38e-04	57	112	3	34878901
Pubmed	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	HFE ABCB11	9.12e-04	14	112	2	20858683
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	CACNA1A SYNE1 RESF1 HOXC13 TNS3	9.69e-04	233	112	5	37704626
Pubmed	GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets.	TNRC6C CNOT3	1.05e-03	15	112	2	21981923
Pubmed	Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns.	CACNA1A PTPN11 TOMM40	1.12e-03	63	112	3	17672918
Pubmed	Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.	GCLC PKLR	1.20e-03	16	112	2	27125672
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	RRP1B APLP2 CHD1 ECI1 TRIM14 TDP2 C2CD5 PTPN11 TNS3 XPOT	1.22e-03	974	112	10	28675297
Pubmed	Alternative exon skipping biases substrate preference of the deubiquitylase USP15 for mysterin/RNF213, the moyamoya disease susceptibility factor.	RAE1 USP32 KPNA2	1.23e-03	65	112	3	28276505
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	KLHL1 MAP3K12 STAT2 FER MKX MAPK4	1.33e-03	372	112	6	22939624
Pubmed	Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.	FADS1 PKLR ABCB11	1.40e-03	68	112	3	22001757
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	KMT2D MED12 CNOT3	1.46e-03	69	112	3	28481362
Pubmed	The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin alpha2.	ARHGEF7 KPNA2	1.52e-03	18	112	2	19961560
Pubmed	Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.	RFX3 ABCB11	1.52e-03	18	112	2	24058526
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	RAE1 SHOC2 C2CD5 PTPN11 TOMM40 SDK1 CNOT3	1.73e-03	533	112	7	25544563
Pubmed	Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.	PTPN11 FER TNS3	2.00e-03	77	112	3	22973453
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC6C KMT2D MED12	1.36e-04	25	73	3	775
GeneFamily	SH2 domain containing	STAT2 PTPN11 FER TNS3	7.43e-04	101	73	4	741
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	PMS1 RAE1 CENPF RALGAPB RFX3 PTPN11 RESF1 MICB MKX MME RAB27B XPOT KPNA2	4.57e-06	721	102	13	M10237
Coexpression	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	FOSL2 BIVM STAT2 GAB2 RESF1 USP32 CD96	1.36e-05	200	102	7	M6247
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	PMS1 RRP1B CENPF CHD1 SHOC2 GCLC ARHGEF7 MICB	2.32e-05	300	102	8	M8702
Coexpression	SMITH_LIVER_CANCER	CENPF HJURP COPS5 RAB4A	3.39e-05	47	102	4	M18761
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A KLHL1 NUP210L SI PTPRT ABCB11	1.36e-06	150	103	6	0205318a870e091add66ee4305747dda9f51510d
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CENPF HJURP SPAG5 MME ANKFN1 KPNA2	1.41e-06	151	103	6	c06a54afe918b14f885d6a85fbcf81e80f33afae
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A KLHL1 NUP210L PTPRT MME ANKFN1	2.54e-06	167	103	6	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A KLHL1 NUP210L SI PTPRT CD96	2.91e-06	171	103	6	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF NT5DC3 PTPRT IL17RE MAPK4 SDK1	3.67e-06	178	103	6	c77a1d1a9aef0ab51b4408b9e84f201219788ca2
ToppCell	3'-Adult-SmallIntestine-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UGT3A1 SI RESF1 MME ALPI MGAM2	4.44e-06	184	103	6	ed7a8e79e5723a5f5a03f542203d9e50bdef5f50
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UGT3A1 SI RESF1 MME ALPI MGAM2	4.72e-06	186	103	6	bdd9d3a432aab46e733469b362f0064d35c1ac49
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UGT3A1 SI RESF1 MME ALPI MGAM2	4.87e-06	187	103	6	9042bd0f57213a51503d9df2e4dce3209b7772d3
ToppCell	3'-Adult-SmallIntestine\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FCRL2 UGT3A1 SI LILRB1 MME ALPI	6.56e-06	197	103	6	1614bc5f41fd2c8385e58ed6b87ef1536421f29a
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	APLP2 IL17RE SCNN1A PKHD1 TNS3 ALPI	6.75e-06	198	103	6	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPFIA3 IL17RE ABCB11 MME ABCC10	1.03e-05	124	103	5	a7b7d8b14d1218194da8fcf69b4780b6e9469332
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA9 HFE JADE2 DOCK5 SCNN1A	3.23e-05	157	103	5	0ad242320ada7bcb9e29548d3050bf4fd3a07115
ToppCell	facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA9 HFE JADE2 DOCK5 SCNN1A	3.23e-05	157	103	5	fe4c9556806203e57522d1986754ebe5a20aa2de
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A KLHL1 NUP210L PTPRT ANKFN1	3.43e-05	159	103	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERPINA6 GCLC PKLR ABCB11 XPOT	3.53e-05	160	103	5	c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3
ToppCell	facs-Spleen-nan-3m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE MRC1 GAB2 DOCK5 TNS3	3.64e-05	161	103	5	45591addc765760db6029ac19e80573373d1d917
ToppCell	facs-Spleen-nan-3m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE MRC1 GAB2 DOCK5 TNS3	3.64e-05	161	103	5	8741b91a62c9a8ce377ef6533d323b65beb93c63
ToppCell	facs-Spleen-nan-3m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE MRC1 GAB2 DOCK5 TNS3	3.64e-05	161	103	5	9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276
ToppCell	PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF SNX20 HJURP SPAG5 KPNA2	4.46e-05	168	103	5	4c402a1613fcf0a6e4d9b9d5551812940e91ff32
ToppCell	10x3'2.3-week_17-19-Lymphocytic_T-T_NK-Treg\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FAM184B SNX20 TRIM14 FSIP2 CD96	5.26e-05	174	103	5	7ca39c9ecd609e5ade30dac1a948a4a4fff1b3b2
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MANBA TEKT5 TRIM14 SCNN1A RAB27B	5.41e-05	175	103	5	0992de1c7bffcb6890584357a7a0a8955927da6c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KLHL1 GRIK1 APOL5 ANKFN1 SDK1	6.18e-05	180	103	5	b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CENPF HJURP SPAG5 MICB KPNA2	6.34e-05	181	103	5	73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRELID1 SNX20 FOSL2 CHD1 LILRB1	6.51e-05	182	103	5	c3eafdc11858566aa7692b2f5dbe72ac01fb769a
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DENND5B CACNA1A RFX3 LILRB1 STAT2	6.68e-05	183	103	5	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	CF-Myeloid-Neutrophil\|CF / Disease state, Lineage and Cell class	GAB2 DOCK5 RESF1 USP32 MME	6.68e-05	183	103	5	da43827952e6fdee2ce94648c316182f272b321c
ToppCell	mild-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	GAB2 DOCK5 RESF1 USP32 MME	6.86e-05	184	103	5	1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPF HJURP SERPINA6 SPAG5 KPNA2	7.59e-05	188	103	5	b3cae49f0665ace0016a6441cbf9ae40755b0ea3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF HJURP MICB CD96 KPNA2	7.98e-05	190	103	5	185ae04c68f825cd346aa65072cc5da6a39dff4a
ToppCell	(0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	MRC1 NUP210L FOSL2 APLP2 ARHGEF7	7.98e-05	190	103	5	ff083168d609957d00888f31b3488d6d56c902b4
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	DENND5B FCRL2 MANBA GAB2 TNS3	7.98e-05	190	103	5	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA1A SYNE1 LRRC69 BTBD9 RAB27B	7.98e-05	190	103	5	600b9674197f743dea1d19d3df0fc993b6e6aa25
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF HJURP MICB CD96 KPNA2	7.98e-05	190	103	5	e38dc41f2e79e3bd51326581c6ebe51927edb549
ToppCell	control-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	GAB2 DOCK5 RESF1 USP32 MME	8.18e-05	191	103	5	db1b3cd07d7d190155b2d14e82e1d124975fbd0b
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHD1 DOCK5 RESF1 USP32 MME	8.18e-05	191	103	5	47156e5f1d790707f42f6283104a44b33af613e5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA1A SYNE1 LRRC69 BTBD9 RAB27B	8.38e-05	192	103	5	c5f77c2103841505d13e09173549811312ef2f01
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA1A SYNE1 LRRC69 BTBD9 RAB27B	8.38e-05	192	103	5	e981162f387a31111c0ae8355dbe9db5785c4838
ToppCell	Severe_COVID-19-Myeloid-proliferating_Myeloid_cells\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CENPF HJURP SPAG5 FADS1 MME	8.59e-05	193	103	5	0d85025690c9cd545cba30abc38acbdd6a39b153
ToppCell	COPD-Myeloid\|COPD / Disease state, Lineage and Cell class	MRC1 MANBA APLP2 GAB2 TNS3	8.59e-05	193	103	5	f58552e286aa27e592497ad78776f58f8ee09841
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF HJURP SPAG5 FADS1 MME	8.80e-05	194	103	5	cb39850e9577015b6b9834e98c36b412bae7d462
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF HJURP SPAG5 FADS1 MME	8.80e-05	194	103	5	408597c9aa302a44b112c1d612c21fbb0227a82a
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CENPF HJURP SPAG5 FADS1 MME	8.80e-05	194	103	5	193cc20fefbd795a4ad59e401a95af47d30603e7
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF HJURP SPAG5 FADS1 MME	8.80e-05	194	103	5	2360b5f995b360419de41612368cab9fb61781a1
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CENPF HJURP SPAG5 FADS1 MME	8.80e-05	194	103	5	903ae11708b0cb24538c6982abd57fe6fa95b8d3
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CENPF HJURP SPAG5 FADS1 MME	8.80e-05	194	103	5	58406502a8cbcc3037f79a1b6a683df408297ae5
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	MRC1 MANBA LILRB1 GAB2 TNS3	9.01e-05	195	103	5	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MRC1 SNX20 SPAG5 FADS1 MME	9.01e-05	195	103	5	c96755d2eb98112b703b5dbee9c88730ace7dcbf
ToppCell	IPF-Myeloid\|IPF / Disease state, Lineage and Cell class	MRC1 MANBA APLP2 GAB2 TNS3	9.01e-05	195	103	5	fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	CACNA1A TRIM14 RFX3 LILRB1 STAT2	9.01e-05	195	103	5	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	Control-Myeloid\|Control / Disease state, Lineage and Cell class	MRC1 MANBA APLP2 GAB2 TNS3	9.01e-05	195	103	5	46ce2e403ca5d757e5ba17349b6c7ce5cde1f195
ToppCell	(4)_B_Hypermutation\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CENPF HJURP SPAG5 MME KPNA2	9.01e-05	195	103	5	54d2acaff6be6b5604591bdbd7d769ac3e74f223
ToppCell	Control-Myeloid-Macrophage\|Control / Disease state, Lineage and Cell class	MRC1 MANBA FOSL2 GAB2 TNS3	9.23e-05	196	103	5	e2c2a30fa3ee3034fbde5335be169e880dde622d
ToppCell	Non-neuronal-Dividing-Radial_Glia-early\|World / Primary Cells by Cluster	PRELID1 CENPF HJURP MME KPNA2	9.23e-05	196	103	5	dd3c6ea5e4ebcc27064f16507de6db6dc8f86fa8
ToppCell	Non-neuronal-Dividing-Radial_Glia-early-1\|World / Primary Cells by Cluster	PRELID1 CENPF HJURP MME KPNA2	9.23e-05	196	103	5	70fe6a1a6de891832aaa6276c985b326985e14db
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-Large_pre-B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CENPF HJURP SPAG5 MME KPNA2	9.46e-05	197	103	5	7e0834b3947031bf244a10624dcf3f2095c79368
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CENPF HJURP SPAG5 MME KPNA2	9.46e-05	197	103	5	cebf47d66f425c84d3fea962e11f5bf4bfe2e60f
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CENPF HJURP PTPRT SPAG5 KPNA2	9.46e-05	197	103	5	196eaecef7003ed83f323c1f157c6a3594650097
ToppCell	IPF-Myeloid-Macrophage\|IPF / Disease state, Lineage and Cell class	MRC1 MANBA APLP2 GAB2 TNS3	9.46e-05	197	103	5	a2ffb33c7cad6be43cbb8ed9a91338923cc07db4
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CENPF HJURP PTPRT SDK1 KPNA2	9.69e-05	198	103	5	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPF HJURP CHRNB4 SPAG5 KPNA2	9.69e-05	198	103	5	2ee8ac82ef1b8ebabc8dd824211bbb471f2af8ac
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CLCA4 FOSL2 PTPRT GCLC SDK1	9.69e-05	198	103	5	19d8ff3a4f911b13ecc34844202925475ad4d2ab
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DENND5B CENPF HJURP SPAG5 KPNA2	9.69e-05	198	103	5	2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CENPF HJURP SPAG5 FADS1 KPNA2	9.92e-05	199	103	5	f0944961f99c600ad5fa588b19321fce991258f7
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	JADE2 SYNE1 TNRC6C RESF1 CD96	9.92e-05	199	103	5	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CENPF HJURP SPAG5 FADS1 KPNA2	9.92e-05	199	103	5	99437f8b57d168c550ccfd1fbda5454c26f971a8
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JADE2 SNX20 LRRC69 MICB CD96	9.92e-05	199	103	5	26bb93347e6722abd174dfa62cab692ce2b7eb23
ToppCell	critical-Lymphoid-NKT-proliferating\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CENPF HJURP SPAG5 SCNN1A KPNA2	9.92e-05	199	103	5	9284956d852e434a91be892e88e06a7c71f8c583
ToppCell	Control-Control-Myeloid-Neutrophil\|Control / Disease, condition lineage and cell class	GAB2 DOCK5 RESF1 USP32 MME	1.02e-04	200	103	5	95c41f147a1594d49e73cb56d86d301c3115ce20
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KLHL1 GRIK1 APOL5 ANKFN1 SDK1	1.02e-04	200	103	5	26f07d271e984f375145e4c10528fba44a5811e1
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KLHL1 GRIK1 APOL5 ANKFN1 SDK1	1.02e-04	200	103	5	c3637827ceba16b0d7956c280dd2ddbc8b1ba55e
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UGT3A1 SI TDP2 MME ALPI	1.02e-04	200	103	5	3e13c9a4ba99a7dfbf738b0fb63fb54b4dee5897
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UGT3A1 SI TDP2 MME ALPI	1.02e-04	200	103	5	73bfdf068a8ecbefc1e6afe9686df73658ee042f
ToppCell	COVID-19-kidney-Epithelial_Doublet\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A OR6B1 FCRL2 PTPRT	1.97e-04	124	103	4	d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A KLHL1 PTPRT HOXC13	2.22e-04	128	103	4	91072ca56bce2c552a95edd67e17f43d8cc1de95
ToppCell	COVID-19-kidney-Epithelial_Doublet\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A OR6B1 KLHL1 PKHD1	2.36e-04	130	103	4	1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b
ToppCell	Control-Hematopoietic_Mast-Mast_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CA9 SNX20 SYCP2 CD96	3.30e-04	142	103	4	a81f7ea4516a869c7c9b9a3f4ef74844ff9fffcd
ToppCell	Control-Hematopoietic_Mast-Mast_cells-T-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CA9 SNX20 SYCP2 CD96	3.30e-04	142	103	4	70f8c1be134835e0d21e6d426b7122f0f5d3d3e5
ToppCell	Control-Hematopoietic_Mast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CA9 SNX20 SYCP2 CD96	3.30e-04	142	103	4	db9b7acbab730ae391a362f1ca8177507e52250d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KLHL1 GRIK1 PTPRT ABCB11	3.39e-04	143	103	4	24fd24846fbef049af669a57d42fcc18928d2b27
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA9 CLCA4 MME ALPI	3.76e-04	147	103	4	a5ed71afe5fcb4f541080f5552252695c7d4d090
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A TEKT5 PTPRT ANKFN1	3.86e-04	148	103	4	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC2 SCNN1A PRSS45P RAB27B	3.86e-04	148	103	4	f58804d24fe524b42b5090c8658050ea4b14793e
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN4_thymocyte\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CENPF HJURP SPAG5 KPNA2	3.96e-04	149	103	4	89faa84af68d4727180f39718964bb3bc65d8fe6
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_ductal_cel\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA9 CLCA4 MME ALPI	3.96e-04	149	103	4	7726957b1de638c3bfc659381d15eab626bb179b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TDP2 C2CD5 IL17RE KPNA2	4.16e-04	151	103	4	c1461d0dd622a081187eba77f454d2663df2732e
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CA9 CENPF ABCB11 KPNA2	4.38e-04	153	103	4	d7635f3d4831c02a94f53afc674847d5b51453be
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CA9 CENPF ABCB11 KPNA2	4.38e-04	153	103	4	54a941950bbb848077c7bd5726da9e4b3244bd38
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P4\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CA9 CENPF ABCB11 KPNA2	4.38e-04	153	103	4	69a8550418ba0fc908a84b3b85761abb6e8ca4c0
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CA9 CENPF ABCB11 KPNA2	4.38e-04	153	103	4	e50d20f9e553b8c3e10e187770d8abe1a43d109e
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CA9 HFE MRC1 TRIM14	4.49e-04	154	103	4	79ebda35dd1719e157738d7c13e5b8ccc3991f03
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	HOXC13 PKHD1 ABCB11	4.59e-04	65	103	3	b7bc23af54d6d2f7afd584f4df42c24d7c49e344
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	HOXC13 PKHD1 ABCB11	4.59e-04	65	103	3	3b3630253f5713c4a688c74c4ea0f98c1fe42594
ToppCell	droplet-Fat-Mat-18m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA4 PPFIA3 PKLR PKHD1	4.71e-04	156	103	4	cfd7f56f3155db677684827607e9008e975dbe70
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	PTPRT ANKFN1 SDK1 CD96	4.71e-04	156	103	4	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	droplet-Fat-Mat-18m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA4 PPFIA3 PKLR PKHD1	4.71e-04	156	103	4	0d79b4172896574b00faf00e87254f68d76f5512
ToppCell	droplet-Fat-Mat-18m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA4 PPFIA3 PKLR PKHD1	4.71e-04	156	103	4	f09150aacb6121f913648ed3918f9cd4f22c61f2
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRT MKX PKHD1 MME	5.18e-04	160	103	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-4\|TCGA-Kidney / Sample_Type by Project: Shred V9	CA9 PRELID1 NT5DC3 CD96	5.18e-04	160	103	4	45cb62a5186f3dd2a2fb86a8ebc952efb78e5e77
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRT MKX PKHD1 MME	5.18e-04	160	103	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	lymphoid-T_cell-pro-T_cell\|T_cell / Lineage, cell class and subclass	DENND5B FAM184B FOSL2 TEKT5	5.18e-04	160	103	4	66fe86d2f37983761141e5bb3de127f0b4bb0951
Disease	Malignant Cystosarcoma Phyllodes	KMT2D MED12	1.18e-04	5	102	2	C0600066
Disease	Phyllodes Tumor	KMT2D MED12	1.18e-04	5	102	2	C0010701
Disease	bilirubin measurement	HFE KLHL1 HJURP PTPN11 ARHGEF7 PKLR TOMM40 MME	1.53e-04	442	102	8	EFO_0004570
Disease	Spinocerebellar Ataxia Type 2	CACNA1A TDP2 MME	2.22e-04	34	102	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	CACNA1A TDP2 MME	2.22e-04	34	102	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	CACNA1A TDP2 MME	2.22e-04	34	102	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	CACNA1A TDP2 MME	2.22e-04	34	102	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	CACNA1A TDP2 MME	2.22e-04	34	102	3	C0752124
Disease	Ataxia, Spinocerebellar	CACNA1A TDP2 MME	2.22e-04	34	102	3	C0087012
Disease	Spinocerebellar Ataxia Type 4	CACNA1A TDP2 MME	2.42e-04	35	102	3	C0752122
Disease	level of Phosphatidylinositol (16:0_18:2) in blood serum	FADS1 CNOT3	3.27e-04	8	102	2	OBA_2045153
Disease	cystic fibrosis (implicated_via_orthology)	CLCN2 ABCB11	4.19e-04	9	102	2	DOID:1485 (implicated_via_orthology)
Disease	Noonan Syndrome 1	SHOC2 PTPN11	6.38e-04	11	102	2	C4551602
Disease	Turner Syndrome, Male	SHOC2 PTPN11	6.38e-04	11	102	2	C0041409
Disease	Enzymopathy	GCLC PKLR	6.38e-04	11	102	2	C0520572
Disease	Female Pseudo-Turner Syndrome	SHOC2 PTPN11	6.38e-04	11	102	2	C1527404
Disease	Cystic Fibrosis	CLCA4 SCNN1A	6.38e-04	11	102	2	C0010674
Disease	depressive symptom measurement	CACNA1A HFE MICB PKHD1 SDK1 MED12 RAB27B	7.08e-04	426	102	7	EFO_0007006
Disease	anxiety disorder, stress-related disorder	PTPRT SDK1	7.64e-04	12	102	2	EFO_0006788, EFO_0010098
Disease	serum alanine aminotransferase measurement	HFE MANBA SERPINA6 GAB2 PTPN11 FADS1 RESF1 APOL5 ABCB11 TOMM40	8.64e-04	869	102	10	EFO_0004735
Disease	peripheral arterial disease	CHRNB4 PTPN11 KPNA2	8.75e-04	54	102	3	EFO_0004265
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	FADS1 CNOT3	9.00e-04	13	102	2	OBA_2045159
Disease	Alzheimer's disease (implicated_via_orthology)	APLP2 TOMM40 MME	1.02e-03	57	102	3	DOID:10652 (implicated_via_orthology)
Disease	diacylglycerol 38:4 measurement	FADS1 CNOT3	1.05e-03	14	102	2	EFO_0020066
Disease	RASopathy	SHOC2 PTPN11	1.21e-03	15	102	2	cv:C5555857
Disease	platelet component distribution width	CAPN14 JADE2 NUP210L HEATR4 SYNE1 GAB2 C2CD5 DOCK5 FADS1	1.24e-03	755	102	9	EFO_0007984
Disease	Prostatic Neoplasms	PMS1 CENPF JADE2 CHD1 KMT2D MME MED12 CNOT3	1.36e-03	616	102	8	C0033578
Disease	Malignant neoplasm of prostate	PMS1 CENPF JADE2 CHD1 KMT2D MME MED12 CNOT3	1.36e-03	616	102	8	C0376358
Disease	Alzheimer disease, psychotic symptoms	TNRC6C TOMM40	1.56e-03	17	102	2	EFO_0005940, MONDO_0004975
Disease	low density lipoprotein cholesterol measurement, physical activity	HFE FADS1 ABCB11	1.57e-03	66	102	3	EFO_0003940, EFO_0004611
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	FADS1 CNOT3	1.75e-03	18	102	2	OBA_2045155
Disease	granulocyte count	CLEC4M FADS1 PKLR MAPK4 TNS3	1.92e-03	254	102	5	EFO_0007987
Disease	Noonan-Like Syndrome With Loose Anagen Hair	SHOC2 PTPN11	1.95e-03	19	102	2	C3501846
Disease	Noonan syndrome-like disorder with loose anagen hair	SHOC2 PTPN11	1.95e-03	19	102	2	C1843181
Disease	Cardio-facio-cutaneous syndrome	SHOC2 PTPN11	1.95e-03	19	102	2	C1275081
Disease	Costello syndrome (disorder)	SHOC2 PTPN11	1.95e-03	19	102	2	C0587248
Disease	diacylglycerol 38:3 measurement	FADS1 CNOT3	1.95e-03	19	102	2	EFO_0020065
Disease	disease of metabolism (implicated_via_orthology)	PTPN11 PKLR	2.38e-03	21	102	2	DOID:0014667 (implicated_via_orthology)
Disease	HbA1c measurement	HFE TNRC6C GAB2 PTPN11 FADS1 PKLR ABCB11 TOMM40	2.40e-03	675	102	8	EFO_0004541
Disease	LEOPARD Syndrome	SHOC2 PTPN11	2.61e-03	22	102	2	C0175704
Disease	triacylglycerol 58:9 measurement	LRRC2 PTPRT	2.61e-03	22	102	2	EFO_0010443
Disease	susceptibility to scarlet fever measurement	MANBA SCNN1A MME	2.62e-03	79	102	3	EFO_0008409
Disease	cleft lip	NUP210L SYNE1 ANKFN1 ABCC10 MGAM2	3.11e-03	284	102	5	EFO_0003959
Disease	alcohol use disorder measurement, alcohol dependence	MICB PKHD1	3.11e-03	24	102	2	EFO_0009458, MONDO_0007079
Disease	lung squamous cell carcinoma (is_implicated_in)	CHRNB4 KMT2D	3.11e-03	24	102	2	DOID:3907 (is_implicated_in)
Disease	Lynch syndrome (is_implicated_in)	PMS1 ASTE1	3.11e-03	24	102	2	DOID:3883 (is_implicated_in)
Disease	Noonan Syndrome	SHOC2 PTPN11	3.11e-03	24	102	2	C0028326
Disease	lung adenocarcinoma	TEKT5 CHRNB4 FADS1 GCLC	3.17e-03	174	102	4	EFO_0000571
Disease	diet measurement	OR6B1 FAM184B NUP210L TAS2R38 SHOC2 RFX3 PTPRT GAB2 PKHD1 SDK1	3.43e-03	1049	102	10	EFO_0008111
Disease	beta-amyloid 1-42 measurement	TEKT5 PTPRT TOMM40	3.44e-03	87	102	3	EFO_0004670

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISVNEREQIMTTNVW	CHRNB4	66	P30926
VTQRAQEMFQKTGTW	CACNA1A	2031	O00555
WLSGIDVSTQMLNQQ	COPS5	146	Q92905
LLVRTQNSWTQDGMN	B4GALT3	306	O60512
WAFMSSRQQTALVRN	GRIK1	721	P39086
TIVWTNSSLNQNMTN	ABCB11	111	O95342
FTGNTTLMRWFRQIN	BIVM	261	Q86UB2
TRQTLNSTWQGTDLM	ARHGEF7	726	Q14155
SRWQQQQAAAASMLR	C1orf232	116	A0A0U1RR37
QREIQTWASQMNAVV	CHD1	546	O14646
NSFQWRNMNTIKGTQ	ASTE1	176	Q2TB18
IWTVFNQTVMLSAKQ	CA9	341	Q16790
VQLQNLLNQMTWSSL	CAPN14	536	A8MX76
QWLTNTIDTLNMQVD	CNOT3	126	O75175
SIISTKTFIMQNWNS	HJURP	281	Q8NCD3
KMWDLSSNQAIQIAQ	RAE1	111	P78406
LTSQQSFLNVRNWMS	RAB27B	101	O00194
NWLTDARMLASQNIV	RAB4A	106	P20338
NVWSLQEITSRFVMN	LRRC69	246	Q6ZNQ3
NFKQMQELNWTSSSI	LRRC9	1091	Q6ZRR7
TNVMEANQRVSIDNW	APLP2	101	Q06481
LNQRCQFATSATMQW	ABCC10	1136	Q5T3U5
WIEMNEVSSLLQASN	MGAM2	476	Q2M2H8
DIVLMAANQSQLSNW	MAPK4	336	P31152
SQTQIRDVMVWSNER	PPFIA3	1031	O75145
AIRQAMQQSVSQALW	FAM184B	231	Q9ULE4
TSWNVSMDTQAQQLI	IL17RE	361	Q8NFR9
SWLNEMNTLFVNNVV	FSIP2	4001	Q5CZC0
NSWLAQSVQITAENM	JADE2	531	Q9NQC1
TQIMRTGQNTWESKN	PCMTD1	196	Q96MG8
QMTLVQVSNWFANAR	MKX	111	Q8IYA7
SQNWSEQRVISVMFL	OR4X1	16	Q8NH49
TNSSQRLCSKQTWTM	FAM214A	261	Q32MH5
MVDSSISNRQSFWQS	FAM214A	341	Q32MH5
DHFENIQSTNWQTMR	GCLC	396	P48506
FSWLNFTNEIMSTVN	MME	321	P08473
MSNLQWLDISSNNLT	LRRC2	236	Q9BYS8
MSIQENISSLQLRSW	PKLR	1	P30613
TVQRSTQQTTEWAML	MED12	1546	Q93074
SRAQTLAMNVTNFWK	MICB	156	Q29980
NTVNDFWRMVFQENS	PTPN11	336	Q06124
LNWSSIEQSQFSELM	FOXJ2	431	Q9P0K8
SSRISSQMWLQLSQS	HFE	76	Q30201
WQENSASIVMVTNLV	PTPRT	976	O14522
TWTMSNITAGRQDQI	KPNA2	356	P52292
VWNRTELMQASLDQS	ALPI	266	P09923
NWSTISQQALMQNEA	ERVK-10	401	P87889
NWSTISQQALMQNEA	ERVK-19	401	Q9YNA8
NWSTISQQALMQNEA	ERVK-21	401	P62683
NWSTISQQALMQNEA	ERVK-24	401	P63145
NWSTISQQALMQNEA	ERVK-6	401	Q7LDI9
NWSTISQQALMQNEA	ERVK-7	401	P63130
NWSTISQQALMQNEA	ERVK-8	401	P62685
NWSTISQQALMQNEA	ERVK-9	401	P63126
NWSTISQQALMQNEA	HERVK_113	401	P62684
QVQSTALSAIAQWMA	ECI1	231	P42126
QLQQMTYSLIEWRSQ	DOCK5	116	Q9H7D0
NEQWQQKLTSVTLEM	CENPF	1606	P49454
NVSKSWLLMIQQTEQ	FER	66	P16591
QANEIMWNNLTAESL	FER	291	P16591
PNDVTLWNTMTLQQQ	DMRT3	386	Q9NQL9
MAAANLTFSQEVVWQ	HEATR4	66	Q86WZ0
RVIQISQFEWNSMAL	FASTKD1	811	Q53R41
VIQTAQDMESWLTNR	DENND5B	521	Q6ZUT9
INAITTSQDLQWMVQ	FOSL2	51	P15408
RNMDWVSTQLQATCN	FADS1	351	O60427
LQSVVDANMNTLRVW	MANBA	376	O00462
QRWPQSLNMRQSLST	MAP3K12	736	Q12852
TTNLSERQVTIWFQN	HOXC13	296	P31276
RWELNAMTTNSNISR	KLHDC3	361	Q9BQ90
QVWSMQQPESSANIR	FCRL2	476	Q96LA5
EVSTNQQQWTMVADR	BTBD9	501	Q96Q07
VASGRTNQSIMVQWQ	SDK1	776	Q7Z5N4
VTSQEWVFQMLSRQN	SCNN1A	496	P37088
FQDISMSNVSWENSQ	PMS1	436	P54277
NNWTSEIQMFTSVRV	C2CD5	716	Q86YS7
LAMNFQDWATASRQI	SERPINA6	156	P08185
WMISANNILQTDIVT	NUP210L	1511	Q5VU65
LTAQELSNSWANNLM	MT-ND4	181	P03905
METSNERVWIALNSN	MRC1	1146	P22897
TQALQNTMQEWTDVR	GAB2	651	Q9UQC2
TTVLFMNNNTRLNWQ	TAS2R38	171	P59533
TVNMWDRNNPVIQSS	TNRC6C	741	Q9HCJ0
SLTSTLQQDWRSMQL	SPAG5	636	Q96R06
QHLFIQTFWQTMNRE	RRP1B	91	Q14684
ISNMNQLSIAWASVL	STAT2	456	P52630
FMNETTAQWRNLSVE	SYNE1	586	Q8NF91
NVTLLCQSQGWMQTF	LILRB1	341	Q8NHL6
FKMTLQQQSTLEQWA	RFX3	556	P48380
MLSSEIRTSFQQQWQ	RESF1	311	Q9HCM1
NTEQYIQTMTWLQTL	NT5DC3	421	Q86UY8
VDPQNQTMTTFTWNI	PRELID1	86	Q9Y255
WTSMVELNLATNQLT	SHOC2	401	Q9UQ13
TLSDQMWRQFTDTNL	TEKT5	326	Q96M29
QNMVKNTTCDWSLTR	PKHD1	636	P08F94
WNETFAEMSRNILNI	SI	1571	P14410
QSSYSTQTWVRQQQM	TNS3	581	Q68CZ2
WSVNNSISFTLCMIQ	OR6B1	86	O95007
NWSTISQQALMQNEA	ERVK-9	401	P63128
VNLCQSWKINNLMST	APOL5	51	Q9BWW9
SNSINWNCRVKMTQQ	ANKFN1	61	Q8N957
QLQTSRSNRFSWMGL	CLEC4M	316	Q9H2X3
TLNSNAWMNDTVIID	CLCA4	496	Q14CN2
LQAQQWMSRGLNTSI	CLCN2	116	P51788
SNSSMTTRELQQYWQ	SNX20	51	Q7Z614
WSQVKQRFSANSMLT	PRSS45P	121	Q7RTY3
SRSQWDMQSTFDNTI	UGT3A1	211	Q6NUS8
QTQTVGFFVQMQWSK	CD96	46	P40200
TQSWKTAQQHLRTMN	SYCP2	1386	Q9BX26
TQQENGSMFSLITWN	TDP2	106	O95551
VTQRLNSQWRQDMSI	RALGAPB	766	Q86X10
NSQWRQDMSISLAAL	RALGAPB	771	Q86X10
DRQMNTNWPASVQVS	ZMIZ2	476	Q8NF64
MAIQTQQSKFVNWQV	TOMM40	176	O96008
DIMNDLSNRVWSISQ	TRIM14	156	Q14142
FSSTLQNWQTTRFME	XPOT	431	O43592
QNWQTTRFMEVEVAI	XPOT	436	O43592
TRTQQSNIWVNMGNV	USP32	611	Q8NFA0
QSQQWTFVASMSIAR	KLHL1	576	Q9NR64
QLWQQQQATAATSMR	KMT2D	2816	O14686